JBSS SANFILIPPO JOHN B & SON INC
Sugar & Confectionery Products · Nasdaq · SEC CIK 880117 · Fiscal year ends 06/28
Financial factors as of 2026-09-24 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.1%
TTM net income YoY-14.6%
TTM EPS YoY-14.9%
Revenue 3-yr CAGR5.9%
Net income 3-yr CAGR-4.6%
Margins
Gross margin17.7%
Operating margin7.0%
Net margin4.8%
FCF margin2.6%
EBITDA margin9.4%
Returns
ROE15.4%
ROA8.9%
ROIC (approx.)15.0%
Asset turnover1.83x
Leverage & solvency
Liabilities / assets44.9%
Debt / equity0.13x
Current ratio1.96x
Interest coverage38.30x
Cash quality & payout
Operating cash flow / net income1.81x
Accruals ratio-7.2%
Payout ratio93.4%
Capex / revenue6.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-25 | FY20252025-06-26 |
|---|---|---|
| Income statement | ||
| Revenue | $1.18B | $1.11B |
| Cost of revenue | $964.49M | $903.77M |
| Gross profit | $211.18M | $203.47M |
| R&D expense | $3.33M | $3.49M |
| SG&A expense | $43.04M | $39.83M |
| Operating income | $89.20M | $84.71M |
| Interest expense | $2.43M | $3.55M |
| Pretax income | $82.97M | $77.86M |
| Income tax | $21.04M | $18.93M |
| Net income | $61.93M | $58.93M |
| EBITDA | $117.40M | $111.64M |
| EPS (basic) | 5.29 | 5.06 |
| EPS (diluted) | 5.26 | 5.03 |
| Dividends declared per share | 4.00 | 2.10 |
| Weighted avg. shares (diluted) | 11.78M | 11.72M |
| Balance sheet | ||
| Cash & equivalents | $1.15M | $585,000 |
| Receivables | $84.31M | $76.66M |
| Inventory | $245.83M | $254.60M |
| Current assets | $349.31M | $346.42M |
| PP&E, net | $255.97M | $178.22M |
| Goodwill | $11.75M | $11.75M |
| Intangibles | $3.39M | $4.43M |
| Total assets | $658.58M | $597.60M |
| Current liabilities | $167.93M | $156.05M |
| Short-term debt | $6.05M | $941,000 |
| Long-term debt | $43.57M | $14.56M |
| Total debt | $49.62M | $15.51M |
| Total liabilities | $278.63M | $236.91M |
| Shareholders' equity | $379.95M | $360.70M |
| Net debt | $48.47M | $14.92M |
| Cash flow statement | ||
| Operating cash flow | $123.84M | $30.55M |
| Capital expenditure | $88.09M | $50.71M |
| Free cash flow | $35.75M | -$20.17M |
| Investing cash flow | -$86.17M | -$50.82M |
| Financing cash flow | -$37.11M | $20.38M |
| Depreciation & amortization | $28.20M | $26.93M |
| Stock-based compensation | $4.21M | $4.52M |
| Dividends paid | $46.76M | $24.40M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.